• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of estradiol receptor investigations and histochemical investigations on enzymes in human mammary cancers.

作者信息

Görlich M, Hecker D, Heise E

出版信息

J Natl Cancer Inst. 1981 Sep;67(3):521-7.

PMID:6944524
Abstract

The best way to predict the responsiveness of human breast carcinomas to hormone therapy is to investigate the estradiol receptor-binding abilities of these tumors. This binding induces many hormone-regulated changes in the activities of several enzymes. Therefore, enzyme activities after short-term organ culture exposed to added hormones were tested to see whether a correlation of enzyme activities exists with estradiol receptor binding. The results from both the estradiol receptor investigations and histochemical investigations on enzymes revealed a high degree of conformity, which confirms the existence of such a correlation. However, for this reason histochemical investigations on enzymes cannot eliminate the discrepancy between the experimentally verified existence of estradiol receptor binding and the response of mammary tumors to hormone therapy, which is not higher than 50-60%.

摘要

相似文献

1
Comparison of estradiol receptor investigations and histochemical investigations on enzymes in human mammary cancers.
J Natl Cancer Inst. 1981 Sep;67(3):521-7.
2
17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.17β-羟基类固醇脱氢酶14影响乳腺癌细胞中的雌二醇水平,是雌激素受体阳性乳腺癌的一个预后标志物。
Cancer Res. 2006 Dec 1;66(23):11471-7. doi: 10.1158/0008-5472.CAN-06-1448.
3
Estradiol 17 beta-dehydrogenase and estradiol binding in human mammary tumors.
Steroids. 1979 Apr;33(4):477-84. doi: 10.1016/0039-128x(79)90020-5.
4
Estrogen synthesis and estradiol binding by human mammary tumors.
Cancer Res. 1978 Aug;38(8):2429-33.
5
Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.关于人类乳腺癌中雌激素形成和转化相关酶调控的最新见解。
J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):221-36. doi: 10.1016/j.jsbmb.2005.02.007.
6
Estradiol receptor and 17 beta-dehydrogenase in normal and abnormal human endometrium.正常及异常人类子宫内膜中的雌二醇受体与17β-脱氢酶
Ann N Y Acad Sci. 1977 Mar 11;286:190-8. doi: 10.1111/j.1749-6632.1977.tb29416.x.
7
Estradiol receptor levels in human breast carcinomas.人类乳腺癌中的雌二醇受体水平
Can Med Assoc J. 1981 Apr 15;124(8):1010-2.
8
Expression of COX-2 and steroid converting enzymes in breast cancer.COX-2和类固醇转化酶在乳腺癌中的表达。
Oncol Rep. 2006 Aug;16(2):219-24.
9
[Steroid hormone receptors and their relevance for the therapy of mammary cancers (author's transl)].
Arch Geschwulstforsch. 1981;51(8):727-36.
10
Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.17β-羟类固醇脱氢酶1与17β-羟类固醇脱氢酶2蛋白表达的比值可预测绝经后乳腺癌患者他莫昔芬治疗的结果。
Clin Cancer Res. 2009 May 15;15(10):3610-6. doi: 10.1158/1078-0432.CCR-08-2599. Epub 2009 Apr 28.